Fresenius Medical Care AG (FMCQF) Raw Materials (2009 - 2025)

Fresenius Medical Care AG (FMCQF) has 17 years of Raw Materials data on file, last reported at $383.3 million in Q4 2025.

• In Q4 2025, Raw Materials rose 4.18% year-over-year to $383.3 million; the TTM figure through Dec 2025 stood at $383.3 million (up 4.18% YoY), while the FY2025 annual figure was $383.3 million, up 4.18% from the prior year.
• Raw Materials improved to $383.3 million in Q4 2025, from $367.9 million in the prior quarter.
• Across five years, Raw Materials topped out at $517.2 million in Q4 2021 and bottomed at $313.2 million in Q4 2022.
• A 5-year average of $394.2 million and a median of $383.3 million in 2025 frame the typical range for Raw Materials.
• Annual changes were most pronounced in 2021 — Raw Materials soared 86.62% — and 2022, when it slumped 39.44%.
• Year by year, Raw Materials stood at $517.2 million in 2021, then slumped by 39.44% to $313.2 million in 2022, then increased by 24.29% to $389.3 million in 2023, then slipped by 5.48% to $367.9 million in 2024, then grew by 4.18% to $383.3 million in 2025.
• The last three Raw Materials figures came in at $383.3 million (Q4 2025), $367.9 million (Q4 2024), and $389.3 million (Q4 2023), per Business Quant data.

Peer Comparison